Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
Clinical trial NCT05502783 · TERMINATED
Trial details
- NCT number
- NCT05502783
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-06-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.